Anaes · Neuromuscular blockade & reversal
Neuromuscular monitoring and the train-of-four
Also known as Train-of-four (TOF) monitoring · Peripheral nerve stimulation · Quantitative neuromuscular monitoring · Acceleromyography · Post-tetanic count
Neuromuscular monitoring is the objective assessment of the depth and recovery of a neuromuscular block by delivering a supramaximal electrical stimulus to a peripheral motor nerve and observing the evoked muscle response. The train-of-four — four stimuli at 2 Hz, 0.5 seconds apart — is the workhorse pattern: it yields a TOF count (the number of detectable twitches, 0 to 4) and a TOF ratio (T4 divided by T1). A non-depolarising block shows fade (ratio below 1.0, with sequential loss of T4 then T3 then T2 then T1) whereas a depolarising phase I block shows no fade (all four twitches reduced proportionally, ratio near 1.0). Residual neuromuscular blockade, defined as a TOF ratio below 0.9 at extubation, causes postoperative airway obstruction, aspiration and hypoxia; the 2023 ASA practice guideline recommends quantitative monitoring whenever a neuromuscular blocker is administered, with a confirmed TOF ratio of at least 0.9 before extubation.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Residual neuromuscular blockade (a TOF ratio below 0.9 at extubation) causes airway weakness, aspiration, hypoxia and reintubation — the modern safe threshold for extubation is a TOF ratio of AT LEAST 0.9, not the older 0.7.
- Subjective (visual or tactile) assessment of train-of-four fade is INSUFFICIENT — it cannot reliably detect residual blockade once the ratio is above about 0.4; always use quantitative (acceleromyography) monitoring whenever a neuromuscular blocker has been given.
- Confirm a TOF ratio of 0.9 or higher AND clinical criteria (sustained head lift, grip strength) before extubation — do not rely on a single modality.
- A depolarising (suxamethonium phase I) block shows NO fade on the train-of-four (all four twitches reduced proportionally, ratio near 1.0), whereas a non-depolarising block shows progressive fade — use this to distinguish the two.
- The facial nerve / orbicularis oculi recovers FASTER than the adductor pollicis — relying on it alone overestimates recovery and risks false reassurance before extubation.
Meet the patient
A 60-year-old woman is extubated after a three-hour abdominal operation. She obeys commands, opens her eyes, and lifts her head for five seconds. The felt TOF count is 4 with no perceptible fade. Three minutes later she obstructs, desaturates, and needs reintubation. Her true TOF ratio was 0.6.[1]
The dangerous range of residual blockade — a TOF ratio of 0.4 to 0.9 — is precisely range human eye and finger cannot perceive. The entire apparatus of monitoring exists to close that blind spot. Hold one principle: the monitor decides, not the eye.[1][14]
References21ShowHide
- [1]Thilen SR, et al. 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade. Anesthesiology, 2023.PMID 36520073
- [2]Tao JC, et al. Current status of neuromuscular reversal and neuromuscular monitoring in China: a cross-sectional survey BMC Anesthesiol, 2026.PMID 42185770
- [3]Krönauer T, et al. [Muscle relaxation and neuromuscular monitoring : Current findings and recommendations for the clinical practice]. Anaesthesiologie, 2026.PMID 42334564
- [4]Felix F, et al. Recurarization in the Post-anesthesia Care Unit One Hour After Sugammadex Administration: A Case Report Cureus, 2026.PMID 42306367
- [5]Jia X, et al. Sugammadex Vs. Neostigmine for Cerebral Perfusion During Emergence From General Anesthesia in Patients Undergoing Carotid Endarterectomy: A Double-Blind Randomized Controlled Trial CNS Neurosci Ther, 2026.PMID 42144995
- [6]Chen Z, et al. Half-dose neostigmine and low dose sugammadex as a reversal agent for vecuronium: a pilot randomized trial Anaesth Crit Care Pain Med, 2026.PMID 42217574
- [7]Leslie K, et al. Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial Lancet Respir Med, 2026.PMID 42263720
- [8]Blobner M, et al. Use of a train-of-four ratio of 0.95 versus 0.9 for tracheal extubation: an exploratory analysis of POPULAR data Br J Anaesth, 2020.PMID 31607388
- [9]Kirmeier E, et al. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study Lancet Respir Med, 2019.PMID 30224322
- [10]Savarese JJ, Ali HH, Murphy JD, et al. Train-of-four nerve stimulation in the management of prolonged neuromuscular blockade following succinylcholine Anesthesiology, 1975.PMID 122883
- [11]Eriksson LI Reduced hypoxic chemosensitivity in partially paralysed man. A new property of muscle relaxants? Acta Anaesthesiol Scand, 1996.PMID 8792879
- [12]Wyon N, Joensen H, Yamamoto Y, Lindahl SG, Eriksson LI Carotid body chemoreceptor function is impaired by vecuronium during hypoxia Anesthesiology, 1998.PMID 9856722
- [13]Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium Anesthesiology, 2000.PMID 10754616
- [14]Brull SJ, Silverman DG Visual and tactile assessment of neuromuscular fade Anesth Analg, 1993.PMID 8394051
- [15]Brull SJ, Silverman DG Visual assessment of train-of-four and double burst-induced fade at submaximal stimulating currents Anesth Analg, 1991.PMID 1952146
- [16]Drenck NE, Ueda N, Olsen NV, Engbaek J, Jensen E, Skovgaard LT, Viby-Mogensen J Manual evaluation of residual curarization using double burst stimulation: a comparison with train-of-four Anesthesiology, 1989.PMID 2929994
- [17]Cammu G, Schepens T, De Neve N, et al. Diaphragmatic and intercostal electromyographic activity during neostigmine, sugammadex and neostigmine-sugammadex-enhanced recovery after neuromuscular blockade: A randomised controlled volunteer study Eur J Anaesthesiol, 2017.PMID 27902641
- [18]Fuchs-Buder T, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents III: The 2023 Geneva revision Acta Anaesthesiol Scand, 2023.PMID 37345870
- [19]Viby-Mogensen J, et al. Posttetanic count (PTC): a new method of evaluating an intense nondepolarizing neuromuscular blockade. Anesthesiology, 1981.PMID 7294384
- [20]Hristovska AM, et al. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database Syst Rev, 2017.PMID 28806470
- [21]Chambers D, et al. Sugammadex for reversal of neuromuscular block after rapid sequence intubation: a systematic review and economic assessment. Br J Anaesth, 2010.PMID 20937718